INTELLIGENT BIO SOLUTIONS INC. Earnings Per Share Disclosure
Basic loss per common share is computed by dividing net loss allocable to common shareholders by the weighted average number of shares of common stock or common stock equivalents outstanding. Diluted loss per common share is computed similar to basic loss per common share except that it reflects the potential dilution that could occur if dilutive securities or other obligations to issue common stock were exercised or converted into common stock.
| Years Ended June 30, | ||||||||
| 2025 | 2024 | |||||||
| Net loss attributable to Intelligent Bio Solutions Inc. | $ | (10,568,733 | ) | $ | (10,156,759 | ) | ||
| Basic and diluted net loss per share attributed to common shareholders | $ | ) | $ | ) | ||||
| Weighted-average number of shares outstanding | ||||||||
| June 30, 2025 | June 30, 2024 | |||||||
| Warrants | 5,508,496 | 6,310,684 | ||||||
About Earnings Per Share Disclosures
The earnings per share disclosure breaks down the calculation from net income to both basic and diluted EPS, revealing the full impact of a company's capital structure on per-share economics. The reconciliation between basic and diluted share counts exposes how many stock options, RSUs, convertible securities, and warrants are potentially dilutive to existing shareholders.
Key signals: a widening gap between basic and diluted shares indicates growing dilution from equity compensation or convertible instruments. Anti-dilutive securities excluded from the diluted calculation deserve attention — they represent latent dilution that will materialize if the stock price rises. Watch for the effect of share buybacks on per-share metrics: EPS growth driven primarily by repurchases rather than income growth signals weakening fundamentals. Compare year-over-year changes in the diluted share count against equity compensation expense to assess whether management is effectively managing dilution.